03 August 2022

Semmelweis University at the international forefront of gene therapy in the field of ophthalmology

Cooperation with Novartis Hungary

With the help of a unique, innovative gene therapy procedure in the treatment center, it is also possible to treat retinal dystrophy, a hereditary eye disease with complete loss of vision. Together with the transfer of the institutional certification, the excellent retinal surgeons and pharmacists of the university received diplomas that prove their knowledge of the ophthalmic gene therapy procedure and their expertise acquired in a training provided by Novartis and accredited by the European Medicines Agency (EMA).